New antibiotics from bacterial natural products

被引:439
作者
Clardy, Jon [1 ]
Fischbach, Michael A. [1 ]
Walsh, Christopher T. [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
关键词
D O I
10.1038/nbt1266
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
For the past five decades, the need for new antibiotics has been met largely by semisynthetic tailoring of natural product scaffolds discovered in the middle of the 20(th) century. More recently, however, advances in technology have sparked a resurgence in the discovery of natural product antibiotics from bacterial sources. In particular, efforts have refocused on finding new antibiotics from old sources ( for example, streptomycetes) and new sources ( for example, other actinomycetes, cyanobacteria and uncultured bacteria). This has resulted in several newly discovered antibiotics with unique scaffolds and/or novel mechanisms of action, with the potential to form a basis for new antibiotic classes addressing bacterial targets that are currently underexploited.
引用
收藏
页码:1541 / 1550
页数:10
相关论文
共 89 条
  • [41] Glycopeptide and lipoglycopeptide antibiotics
    Kahne, D
    Leimkuhler, C
    Wei, L
    Walsh, C
    [J]. CHEMICAL REVIEWS, 2005, 105 (02) : 425 - 448
  • [42] Enzymology of acyl chain macrocyclization in natural product biosynthesis
    Kohli, RM
    Walsh, CT
    [J]. CHEMICAL COMMUNICATIONS, 2003, (03) : 297 - 307
  • [43] Mechanisms of EF-Tu, a pioneer GTPase
    Krab, IM
    Parmeggiani, A
    [J]. PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 71, 2002, 71 : 513 - 551
  • [44] Novel lipoglycopeptides as inhibitors of bacterial signal peptidase I
    Kulanthaivel, P
    Kreuzman, AJ
    Strege, MA
    Belvo, MD
    Smitka, TA
    Clemens, M
    Swartling, JR
    Minton, KL
    Zheng, F
    Angleton, EL
    Mullen, D
    Jungheim, LN
    Klimkowski, VJ
    Nicas, TI
    Thompson, RC
    Peng, SB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (35) : 36250 - 36258
  • [45] Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis
    Li, B
    Yu, JPJ
    Brunzelle, JS
    Moll, GN
    van der Donk, WA
    Nair, SK
    [J]. SCIENCE, 2006, 311 (5766) : 1464 - 1467
  • [46] MacNeil IA, 2001, J MOL MICROB BIOTECH, V3, P301
  • [47] Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites
    Magarvey, NA
    Keller, JM
    Bernan, V
    Dworkin, M
    Sherman, DH
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2004, 70 (12) : 7520 - 7529
  • [48] Biosynthetic pathway for mannopeptimycins, lipoglycopeptide antibiotics active against drug-resistant gram-positive pathogens
    Magarvey, Nathan A.
    Haltli, Brad
    He, Min
    Greenstein, Michael
    Hucul, John A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (06) : 2167 - 2177
  • [49] Microbial Genomics as a guide to drug discovery and structural elucidation: ECO-02301, a novel antifungal agent, as an example
    McAlpine, JB
    Bachmann, BO
    Piraee, M
    Tremblay, S
    Alarco, AM
    Zazopoulos, E
    Farnet, CM
    [J]. JOURNAL OF NATURAL PRODUCTS, 2005, 68 (04): : 493 - 496
  • [50] Combinatorial polyketide biosynthesis by de novo design and rearrangement of modular polyketide synthase genes
    Menzella, HG
    Reid, R
    Carney, JR
    Chandran, SS
    Reisinger, SJ
    Patel, KG
    Hopwood, DA
    Santi, DV
    [J]. NATURE BIOTECHNOLOGY, 2005, 23 (09) : 1171 - 1176